KOREA PHARMA Market Cap

KOREA PHARMA has a market cap or net worth of 128.15 billion as of April 28, 2026. Its market cap has decreased by -18.40% in one year.

Market Cap

128.15B

Enterprise Value

139.56B

Revenue

87.60B

Ranking

n/a

PE Ratio

n/a

Stock Price

11,750.00

Market Cap Chart

Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 128.15B, a decrease of -30.27%. That is a compound annual growth rate of -6.11%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	128.15B	-9.62%
Dec 30, 2025	141.79B	-15.09%
Dec 30, 2024	166.98B	-35.26%
Dec 28, 2023	257.94B	10.51%
Dec 29, 2022	233.40B	-55.92%
Dec 30, 2021	529.52B	118.69%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HYUNDAI BIOLAND	133.50B
WITHUS PHARMACEUTICAL Co.,LTD.	120.80B
Pharos iBio	120.14B
DongKoo Bio & Pharma	141.97B
PHARMARESEARCH BIO	146.33B
Kyung Dong Pharmaceutical	151.68B
Organoidsciences	155.42B
H.PIO	105.87B

Market Cap Rankings